Nanoerythrosomes, a new derivative of erythrocyte ghost II: identification of the mechanism of action
Moorjani, M.; Lejeune, A.; Gicquaud, C.; Lacroix, J.; Poyet, P.; Gaudreault, R.C.
Anticancer Research 16(5a): 2831-2836
1996
ISSN/ISBN: 0250-7005 PMID: 8917393 Document Number: 462931
We have recently developed a new drug which is a carrier from red blood cell membrane. This carrier, named nanoerythrosome (nEryt), is prepared by extrusion of erythrocyte ghosts to produce small vesicles having an average diameter of 100 nm. Daunorubicin (DNR) was covalently conjugated to the nEryt (nEryt-DNR) using glutaraldehyde as homobifunctional linking arm. This led to a complex that is more active than free DNR both in vitro and in vivo. In this study, we identified the mechanisms that make the complex nEryt-DNR more active than free DNR. Using fluorescence microscopy and cellular uptake, we observed that the nEryt-DNR complex cannot diffuse through the cell membrane and do not enter the cell by endocytosis. Our results suggest that the nEryt-DNR is rapidly adsorbed onto the cell membrane. Free DNR is then slowly released by hydrolysis of the glutaraldehyde linking arm, producing a high concentration of free DNR in the cell's vicinity over a long period of time.